Cadre (CDRE) Stifel 2024 Cross Sector Insight Conference summary
Event summary combining transcript, slides, and related documents.
Stifel 2024 Cross Sector Insight Conference summary
31 Jan, 2026Business overview and strategic direction
Focused on protective equipment for law enforcement, military, and expanding into engineered safety products.
Maintains leading global share in EOD (bomb suits), holsters, and body armor.
Four acquisitions since going public: Radar Holster (Europe), Cyalume Technologies (chemiluminescence), ICOR Technology (EOD robotics), and Alpha Safety (nuclear sector diversification).
Diversification into new verticals and geographies, especially Europe and nuclear safety.
Market dynamics and resilience
Law enforcement budgets for protective equipment remain stable despite macroeconomic or political shifts.
Business proved resilient during COVID and Defund the Police, as products are mandatory for officers.
Headcount in law enforcement has stabilized, with ongoing recruit classes filling open positions.
International and federal markets are approached selectively, focusing on niches with value-added products and stable demand.
Growth, innovation, and operational strategy
Organic growth typically tracks 3–5% annually, with some lumpiness due to large project timing.
Innovation drives new product launches in holsters, tactical body armor, and digital sizing tools.
Automation and lean manufacturing are in early stages, with cobots implemented and more projects planned.
Dedicated resources are driving operational improvements, with significant runway for further gains.
Latest events from Cadre
- Strong FY2025 results and disciplined M&A fuel growth, with FY2026 sales guidance up to $758M.CDRE
Investor presentation23 Mar 2026 - Record EBITDA and net income growth in 2025, with double-digit 2026 outlook and higher dividend.CDRE
Q4 202511 Mar 2026 - Nuclear safety and engineered products drive growth, margin expansion, and resilience.CDRE
Investor Day 20253 Feb 2026 - Apex armor and robotics launches showcase innovation and global expansion focus.CDRE
Investor Update1 Feb 2026 - Q2 net sales up 19% to $144.3M, adjusted EBITDA margin 19.6%, 2024 guidance unchanged post-cyber event.CDRE
Q2 20241 Feb 2026 - Cybersecurity incidents hit Q3, but record backlog and acquisitions support strong outlook.CDRE
Q3 202416 Jan 2026 - Strong market positions and strategic acquisitions drive growth in public safety and nuclear sectors.CDRE
CJS Securities 26th Annual "New Ideas for the New Year” Investor Conference14 Jan 2026 - Strong Q3 2025 results and strategic acquisitions drive growth in safety and nuclear markets.CDRE
Investor presentation14 Jan 2026 - £75M acquisition doubles global nuclear scale and expands safety, robotics, and medicine reach.CDRE
M&A Announcement10 Jan 2026